Maryland Goes a Step Further to Rein in Drug Price Spikes
[...] The bill has drawn criticism from industry groups and others who say such independent audits would be overly burdensome for industry and that the $2500 threshold might include too many drugs as other states have included a $10,000 threshold, though other experts think the legislation is a step in the right direction. [...]
Read the Full Round-Up
Tags
health care finance health law policy pharmaceuticals public health rachel sachs regulation